2022-10-21

ROI-NJ: BD’s new Onclarity HPV test greatly improves standard of care for women

ROI-NJ: BD’s new Onclarity HPV test greatly improves standard of care for women

Molly Broache, Associate Director, Medical Affairs for US IDS explains how the BD Onclarity™ HPV Assay positively impacts public health by providing a more precise estimate of a woman’s risk of cervical precancer and cancer.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

New study shows substandard approaches to diagnosis and treatment for vaginal discharge syndromes
Vaginitis | News & Updates
Press release: New study shows substandard approaches to diagnosis and treatment for vaginal discharge syndromes
Women's Health STIs
Vaginitis | Brochures
Get her vaginitis diagnosis right the first time with the BD Vaginal Panel
BD Onclarity™ HPV Assay with extended genotyping
Cervical Cancer | Brochures
BD Onclarity™ HPV Assay with extended genotyping